MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 256 filers reported holding MIRATI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $250,400,260 | +253.0% | 5,748,399 | +466.0% | 8.45% | +303.5% |
Q3 2022 | $70,928,000 | +72.3% | 1,015,572 | +102.9% | 2.09% | +62.5% |
Q1 2022 | $41,161,000 | -49.9% | 500,622 | +7.8% | 1.29% | -54.9% |
Q3 2021 | $82,139,000 | +9.5% | 464,298 | 0.0% | 2.86% | +2.0% |
Q2 2021 | $74,998,000 | -5.7% | 464,298 | 0.0% | 2.80% | -20.5% |
Q1 2021 | $79,534,000 | -22.0% | 464,298 | 0.0% | 3.53% | -35.6% |
Q4 2020 | $101,978,000 | +32.3% | 464,298 | 0.0% | 5.48% | -0.3% |
Q3 2020 | $77,097,000 | +88.7% | 464,298 | +29.7% | 5.50% | +82.2% |
Q2 2020 | $40,856,000 | +48.5% | 357,849 | 0.0% | 3.02% | +5.0% |
Q1 2020 | $27,508,000 | +228.4% | 357,849 | +450.5% | 2.87% | +280.7% |
Q4 2019 | $8,376,000 | +143.1% | 65,000 | +47.0% | 0.76% | +73.6% |
Q3 2019 | $3,445,000 | -94.4% | 44,221 | -92.6% | 0.44% | -93.0% |
Q2 2019 | $61,564,000 | -16.0% | 597,711 | -40.2% | 6.22% | -7.9% |
Q1 2019 | $73,300,000 | +167.0% | 1,000,000 | +54.5% | 6.76% | +146.0% |
Q4 2018 | $27,453,000 | +1357.2% | 647,169 | +526.9% | 2.75% | +1195.8% |
Q4 2017 | $1,884,000 | – | 103,240 | – | 0.21% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |